(Reuters) – Fresenius Medical Care, the world’s largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments.
The German company said its adjusted operating income grew 31% to 489 million euros ($512.3 million) in the final quarter of 2024, beating analysts’ estimate of 481 million euros in a company-provided consensus.
($1 = 0.9546 euros)
(Reporting by Isabel Demetz in Gdansk; Editing by Milla Nissi)
Comments